reference/16314854

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16314854

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	201
issn	0028-3908
pageRange	195-201
publicationName	Neuropharmacology
startingPage	195
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9ba0461b347eebde4671a851dc56fa4b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_350e534978c2065733b17b4bcface19a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bbb51632b2d0ae6f8c2367d508317cfa http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0300323fa74a0c0be971993b27842bc1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1d99bf1d61320fa1cac5c823767a57fd
bibliographicCitation	Mendez MA, Horder J, Myers J, Coghlan S, Stokes P, Erritzoe D, Howes O, Lingford-Hughes A, Murphy D, Nutt D. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study. Neuropharmacology. 2013 May;68():195–201. doi: 10.1016/j.neuropharm.2012.04.008.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bb505aa12a42ef67b9b3018642974c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59924f5c99ac4949cf9839ec30fb3f35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66e64e7e9debd1933e042ca7dc565e27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b142417de310a9b3b6339db417511af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e907f85936568bb5a68c384c100374d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1286-1401 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05963dcb4e084b5699ff0e0e48d8cb9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_656e36ee93a4f5ee52c816fc907920fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef99ed23ff8b733083ece55c0ebeeb2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d4af24f258c60da0a8fbfec702a57f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2928-1972 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3627f9d1d6a83fcfee4a3281173694a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7022-6211
date	201305
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4489617 https://doi.org/10.1016/j.neuropharm.2012.04.008 https://pubmed.ncbi.nlm.nih.gov/22546616
isPartOf	https://portal.issn.org/resource/ISSN/0028-3908 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6077
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study
discusses	http://id.nlm.nih.gov/mesh/M0018590 http://id.nlm.nih.gov/mesh/M0351591
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001321Q000378 http://id.nlm.nih.gov/mesh/D001921Q000378 http://id.nlm.nih.gov/mesh/D011963Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011877 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D021122Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001321Q000000981 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D001921Q000000981
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5081 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11494 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7815696ecbf1c96e6894b779456d330e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6515 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b1c87d3c14e005652baabfffa0fa1c5b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2558 http://rdf.ncbi.nlm.nih.gov/pubchem/conserveddomain/PSSMID349839

Total number of triples: 59.